Anna Rivkin

Company: Foghorn Therapeutics

Job title: Chief Business Officer

Seminars:

Pharma Icebreaker: Activity & Ambition for Deal Making to Expand the Drug Discovery Toolbox 8:45 am

• Understanding and appreciating why pharma would invest: What gap are the innovative technologies filling and what problem are they solving? • How do research collaborations support translational efficiency of protein degradation clinical development? Where do we need to improve to clinically validate more protein degradation programs? • Which technologies and targets invite interest –…Read more

day: Conference Day 1

Business Panel: Effectively & Efficiently Structuring Deal Processes as an Early-Stage Company in TPD 11:45 am

• Discussing the panel’s experience executing deals, including how to manage alliances to grow more deals • Outlining opportunities and experience for creative deal structures, and when and where they would be appropriateRead more

day: Conference Day 1

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.